Natural Compound Blocks New Cancer Cell Energy Pathway Identified

A natural substance derived from ginger has been found to disrupt an emerging energy pathway in cancer cells, offering new possibilities for targeted therapies and cancer treatment strategies.
Researchers from Osaka Metropolitan University have uncovered a promising natural compound that can interfere with a novel energy pathway used by certain cancer cells. The compound, ethyl p-methoxycinnamate, a key component of kencur ginger, was shown to inhibit the production of ATP—the energy molecule vital for cell survival—by disrupting fatty acid synthesis and lipid metabolism. Interestingly, instead of targeting glycolysis, which is the common energy source in cancer cells, this compound affects alternative metabolic routes. When exposed to ethyl p-methoxycinnamate, cancer cells increased glycolytic activity as a survival response, indicating an adaptive mechanism that prevents cell death. These insights expand our understanding of cancer metabolism, particularly the Warburg effect, and open new avenues for therapeutic strategies. The study suggests that targeting fatty acid synthesis pathways could be an effective approach in cancer treatment, especially given the compound's ability to cripple ATP production without inducing apoptosis. The findings highlight the importance of exploring natural substances for novel anti-cancer agents and contribute to the growing field of cancer metabolism research.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into Key Genes Driving Colon Cancer Progression
Recent research highlights the critical role of the SOX9 gene in suppressing colon cancer progression and metastasis, revealing potential targets for future therapies.
Innovative Technique Enables Real-Time Visualization of Electrical and Calcium Signals in Patient-Derived Heart Cells
A groundbreaking technique now allows simultaneous, long-term visualization of electrical activity and calcium transients in patient-derived heart cells, enhancing cardiac disease research and drug development.
Blood Test Demonstrates 95% Accuracy in Diagnosing Alzheimer's Disease in Outpatient Clinics
Mayo Clinic researchers have developed a blood test that diagnoses Alzheimer's disease with 95% accuracy in outpatient settings, offering a more accessible and cost-effective diagnostic tool.